LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Genequine Biotherapeutics GmbH
Headquarters:
Hamburg, Germany
Website:
http://www.genequine.com
Year Founded:
2012
Status:
Private
BioCentury
|
Oct 11, 2021
Deals
With CVR, Pacira’s deal for Flexion could nearly double in size
Analgesics company Pacira adds marketed osteoarthritis therapy, with more upside for Flexion shareholders
Read More
BioCentury
|
Aug 23, 2019
Targets & Mechanisms
New targets in osteoarthritis are about more than just pain
With mechanistic insights and a nudge from FDA, companies are taking OA past analgesics into disease-modifying targets
Read More
BioCentury
|
Jul 27, 2018
Product R&D
Syncona’s sister act
How Syncona's family of five gene therapy portfolio companies share recipes
Read More
BioCentury
|
Dec 22, 2014
Emerging Company Profile
Work horse gene therapy
GeneQuine's gene therapy could achieve sustained IL-1 blockade for osteoarthritis
Read More
BioCentury
|
Apr 4, 2013
Targets & Mechanisms
Proteoglycans on the knee
Read More
BioCentury
|
Mar 28, 2013
Distillery Therapeutics
Indication: Musculoskeletal disease
Read More
Items per page:
10
1 - 6 of 6